-
1
-
-
84863303859
-
-
Center for Statistic Information Ministry of Health, P.R. China China Pharmaceutical Technology Exchange
-
Center for Statistic Information Ministry of Health, P.R. China (2002). Statistic bulletin of national health development in 2001. China Pharmaceutical Technology Exchange, 4, 4-7.
-
(2002)
Statistic bulletin of national health development in 2001
, vol.4
, pp. 4-7
-
-
-
2
-
-
3042531736
-
Studies on anti-tumor agents II Synthesis and anti-cancer activity of dehydrogenated carboncyclic analogs of norcantharidin
-
Fang Y (1993). Studies on anti-tumor agents II. Synthesis and anti-cancer activity of dehydrogenated carboncyclic analogs of norcantharidin. Acta Pharmaceutica Sinica, 28, 931-5.
-
(1993)
Acta Pharmaceutica Sinica
, vol.28
, pp. 931-935
-
-
Fang, Y.1
-
3
-
-
0037352153
-
Adjuvant chemotherapy in colon cancer: what is the evidence?
-
Haydon A (2003). Adjuvant chemotherapy in colon cancer: what is the evidence? Intern Med J, 33, 119-24.
-
(2003)
Intern Med J
, vol.33
, pp. 119-124
-
-
Haydon, A.1
-
4
-
-
0041885405
-
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089
-
Le Voyer TE, Sigurdson ER, Hanlon AL, et al. (2003). Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol, 21, 2912-9.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2912-2919
-
-
Le Voyer, T.E.1
Sigurdson, E.R.2
Hanlon, A.L.3
-
5
-
-
78650685309
-
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors
-
Li Y, Huang XE, Yan PW, et al. (2010). Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors. Asian Pac J Cancer Prev, 11, 1119-23.
-
(2010)
Asian Pac J Cancer Prev
, vol.11
, pp. 1119-1123
-
-
Li, Y.1
Huang, X.E.2
Yan, P.W.3
-
6
-
-
85008362882
-
Effect of Aidi Injection combined with chemotherapy for advanced tumor in clinic
-
Liu J, Rao R, Ding J, et al (2001). Effect of Aidi Injection combined with chemotherapy for advanced tumor in clinic. China J Cancer Prev Treat, 8, 667-8.
-
(2001)
China J Cancer Prev Treat
, vol.8
, pp. 667-668
-
-
Liu, J.1
Rao, R.2
Ding, J.3
-
7
-
-
84867425171
-
Clinical efficacy observation of Aidi Injection combined with Gemcitabine and Carboplatin regimen on treatment for 29 cases elder advanced small cell lung cancer
-
Lu L (2009).Clinical efficacy observation of Aidi Injection combined with Gemcitabine and Carboplatin regimen on treatment for 29 cases elder advanced small cell lung cancer. J of Shanxi College of Traditional Chinese Medicine, 10, 66-7.
-
(2009)
J of Shanxi College of Traditional Chinese Medicine
, vol.10
, pp. 66-67
-
-
Lu, L.1
-
8
-
-
3042570916
-
Preliminary study on inhibition of astragalus root and acanthopanax root on human oophoroma
-
Ma D (2007). Preliminary study on inhibition of astragalus root and acanthopanax root on human oophoroma. Tumor, 2, 51.
-
(2007)
Tumor
, vol.2
, pp. 51
-
-
Ma, D.1
-
9
-
-
30944445619
-
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer
-
Masi G, Cupini S, Marcucci L, et al. (2006). Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol, 13, 58-65.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 58-65
-
-
Masi, G.1
Cupini, S.2
Marcucci, L.3
-
10
-
-
0019365237
-
Reporting results of cancer treatment
-
Miller AB, Hoogstraten B, Staquet M, et al. (1981). Reporting results of cancer treatment. Cancer, 47, 207-14.
-
(1981)
Cancer
, vol.47
, pp. 207-214
-
-
Miller, A.B.1
Hoogstraten, B.2
Staquet, M.3
-
11
-
-
14944385553
-
Global cancer statistics 2002
-
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002(2005). CA Cancer J Clin, 55, 74-108.
-
(2005)
CA Cancer J Clin
, vol.55
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
-
12
-
-
0024324299
-
Cancer pain: epidemiology and syndromes
-
Portenoy RK (1989). Cancer pain: epidemiology and syndromes. Cancer, 63, 2298-307.
-
(1989)
Cancer
, vol.63
, pp. 2298-2307
-
-
Portenoy, R.K.1
-
13
-
-
51549117737
-
-
(eds).National Cancer Institute, Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER Website in 2008, accessed March 21, 2008
-
Ries LAG, Melbert D, Krapcho M, et al. (2008). (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute, Bethesda, MD, based on November 2007 SEER data submission, posted to the SEER Website in 2008. Available at http://seer.cancer.gov/csr/1975_2005/, accessed March 21, 2008.
-
(2008)
SEER Cancer Statistics Review, 1975-2005
-
-
Ries, L.A.G.1
Melbert, D.2
Krapcho, M.3
-
14
-
-
4444245366
-
Norcantharidin induces apoptosis in human breast cancer cell line
-
Rong Y, Liang F-Y, Chen L, et al. (2000). Norcantharidin induces apoptosis in human breast cancer cell line. Cancer, 19, 1077-81.
-
(2000)
Cancer
, vol.19
, pp. 1077-1081
-
-
Rong, Y.1
Liang, F.-Y.2
Chen, L.3
-
15
-
-
42949149159
-
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
-
Saltz L, Clarke S, Diaz-Rubio E, et al. (2008). Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol, 26, 2013-9.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2013-2019
-
-
Saltz, L.1
Clarke, S.2
Diaz-Rubio, E.3
-
16
-
-
84867430477
-
Clinical observation of Aidi Injection combined with XELOX regimen on treatment for advanced colorectal cancer
-
Shi B, Xu J, Zhang X (2009). Clinical observation of Aidi Injection combined with XELOX regimen on treatment for advanced colorectal cancer. Modern J Integr Trad Chinese Western Med, 18, 2549.
-
(2009)
Modern J Integr Trad Chinese Western Med
, vol.18
, pp. 2549
-
-
Shi, B.1
Xu, J.2
Zhang, X.3
-
17
-
-
35548966218
-
Objectives of chemotherapy for unresectable liver metastases: Best response or resection?
-
Sobrero A, De Cian F, Andretta V, et al. (2007). Objectives of chemotherapy for unresectable liver metastases: Best response or resection? Eur J Cancer, 5, 317-21.
-
(2007)
Eur J Cancer
, vol.5
, pp. 317-321
-
-
Sobrero, A.1
De Cian, F.2
Andretta, V.3
-
18
-
-
33645309877
-
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): A multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
-
Souglakos J, Androulakis N, Syrigos K, et al. (2006). FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): A multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer, 94, 798-805.
-
(2006)
Br J Cancer
, vol.94
, pp. 798-805
-
-
Souglakos, J.1
Androulakis, N.2
Syrigos, K.3
-
19
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, et al. (2000). New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 92, 205-16.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
20
-
-
84863075729
-
Ubenimex capsule Improves General Performance and Chemotherapy related Toxicity in Advanced Gastric Cancer Cases
-
Xu JW, Li CG, Huang XE, et al. (2011). Ubenimex capsule Improves General Performance and Chemotherapy related Toxicity in Advanced Gastric Cancer Cases. Asian Pac J Cancer Prev, 12, 985-7.
-
(2011)
Asian Pac J Cancer Prev
, vol.12
, pp. 985-987
-
-
Xu, J.W.1
Li, C.G.2
Huang, X.E.3
-
21
-
-
0042807562
-
Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer
-
Yamaue H, Tanimura H, Kono N, et al. (2003). Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer. Anticancer Res, 23, 2559-64.
-
(2003)
Anticancer Res
, vol.23
, pp. 2559-2564
-
-
Yamaue, H.1
Tanimura, H.2
Kono, N.3
-
22
-
-
78650705200
-
Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion
-
Yao CY, Huang XE, Tang JH, et al. (2010). Clinical observations on safety of fixed dose rate gemcitabine chemotherapy by intravenous infusion. Asian Pac J Cancer Prev, 11, 553-5.
-
(2010)
Asian Pac J Cancer Prev
, vol.11
, pp. 553-555
-
-
Yao, C.Y.1
Huang, X.E.2
Tang, J.H.3
-
23
-
-
84863014075
-
Extended full-thickness transanal local excision to treat ultra-low rectal cancer: an initial clinical exploration
-
Zhou X, Huang XE, Zhang T, et al. (2011). Extended full-thickness transanal local excision to treat ultra-low rectal cancer: an initial clinical exploration. Asian Pac J Cancer Prev, 12, 1045-8.
-
(2011)
Asian Pac J Cancer Prev
, vol.12
, pp. 1045-1048
-
-
Zhou, X.1
Huang, X.E.2
Zhang, T.3
|